Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04830202
Brief Title: Expanded Access to Telisotuzumab Vedotin

First Submitted : March 31, 2021
First Submitted that Met QC Criteria : March 31, 2021
First Posted : April 5, 2021

Last Update Submitted that Met QC Criteria : March 31, 2021
Last Update Posted : April 5, 2021